Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.

Launched by GROUPE HOSPITALIER DIACONESSES CROIX SAINT-SIMON · Jun 15, 2016

Keywords

ClinConnect Summary

This clinical trial is studying the quality of life for patients who have a prosthetic joint infection (PJI) and are receiving a treatment called prolonged suppressive antibiotherapy (PSA). This treatment is used for patients who cannot have surgery or prefer not to undergo another operation. The goal of the study is to gather more information about how well PSA works and how patients tolerate it over a long period of time, which is important because there isn't much data available on this treatment option.

To participate in this study, you need to be at least 18 years old and have an infection in your hip or knee joint replacement that cannot be treated with surgery. Participants will be followed for at least two years to assess their experiences and quality of life while on this antibiotic treatment. If you're interested in joining, it's important to note that patients who are not eligible for surgical treatment and live in a stable location for the study period will be considered. This study is currently recruiting participants, and all genders are welcome to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient aged over 18 years old with hip or knee prosthetic infection who consented to participate in the study
• • Non-eligible patient to surgical treatment
• • Patient eligible to prolonged suppressive antibiotherapy
• Exclusion Criteria:
• • patient who does not meet eligibility criteria
• • Patient living or traveling abroad for whom 2 years minimum follow up is impossible.
• • Patient lawfully deprived of his liberty
• • Patient not insured under social security scheme